Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for metabolic syndrome in adults with bipolar disorder
ChiCTR1900027173Phase 4Recruiting
- Sponsor
- Hefei Fourth People's Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atorvastatin in cardiometabolic risk (CMR) (2 arms), sponsored by Hefei Fourth People's Hospital. Primary endpoints: Insulin resistance and Inflammatory factors. Started Nov 2019; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on ChiCTR1900027173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027173.